SCORPIUS HOLDINGS INC (SCPX) Fundamental Analysis & Valuation
NYSEARCA:SCPX • US42237K5083
Current stock price
0.068 USD
-0.06 (-48.48%)
Last:
This SCPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SCPX Profitability Analysis
1.1 Basic Checks
- SCPX had negative earnings in the past year.
- In the past year SCPX has reported a negative cash flow from operations.
- In the past 5 years SCPX always reported negative net income.
- SCPX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -72.96%, SCPX is doing worse than 66.49% of the companies in the same industry.
- SCPX has a Return On Equity of -128.83%. This is in the lower half of the industry: SCPX underperforms 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -72.96% | ||
| ROE | -128.83% | ||
| ROIC | N/A |
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SCPX's Gross Margin of 68.54% is amongst the best of the industry. SCPX outperforms 80.60% of its industry peers.
- The Profit Margin and Operating Margin are not available for SCPX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. SCPX Health Analysis
2.1 Basic Checks
- SCPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, SCPX has more shares outstanding
- SCPX has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -9.40, we must say that SCPX is in the distress zone and has some risk of bankruptcy.
- SCPX's Altman-Z score of -9.40 is on the low side compared to the rest of the industry. SCPX is outperformed by 72.66% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that SCPX is not too dependend on debt financing.
- SCPX's Debt to Equity ratio of 0.31 is on the low side compared to the rest of the industry. SCPX is outperformed by 71.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.4 |
ROIC/WACCN/A
WACC4.43%
2.3 Liquidity
- SCPX has a Current Ratio of 0.38. This is a bad value and indicates that SCPX is not financially healthy enough and could expect problems in meeting its short term obligations.
- SCPX has a worse Current ratio (0.38) than 94.36% of its industry peers.
- A Quick Ratio of 0.26 indicates that SCPX may have some problems paying its short term obligations.
- With a Quick ratio value of 0.26, SCPX is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.26 |
3. SCPX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 20.42% over the past year.
- SCPX shows a strong growth in Revenue. In the last year, the Revenue has grown by 947.53%.
- Measured over the past years, SCPX shows a small growth in Revenue. The Revenue has been growing by 3.85% on average per year.
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%
3.2 Future
- Based on estimates for the next years, SCPX will show a very strong growth in Earnings Per Share. The EPS will grow by 41.10% on average per year.
- SCPX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.70% yearly.
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. SCPX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for SCPX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SCPX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as SCPX's earnings are expected to grow with 41.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.1%
EPS Next 3YN/A
5. SCPX Dividend Analysis
5.1 Amount
- No dividends for SCPX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SCPX Fundamentals: All Metrics, Ratios and Statistics
NYSEARCA:SCPX (4/21/2025, 8:04:00 PM)
0.068
-0.06 (-48.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-26 2025-05-26
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner Change0%
Market Cap331.16K
Revenue(TTM)9.74M
Net Income(TTM)-36.85M
Analysts82.86
Price Target5.1 (7400%)
Short Float %0.13%
Short Ratio0
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.01 | ||
| P/tB | 0.01 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.38
EYN/A
EPS(NY)-2.97
Fwd EYN/A
FCF(TTM)-4.74
FCFYN/A
OCF(TTM)-4.61
OCFYN/A
SpS2
BVpS5.87
TBVpS5.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -72.96% | ||
| ROE | -128.83% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.54% | ||
| FCFM | N/A |
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 10.24% | ||
| Cap/Sales | 6.83% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.26 | ||
| Altman-Z | -9.4 |
F-Score3
WACC4.43%
ROIC/WACCN/A
Cap/Depr(3y)326.96%
Cap/Depr(5y)240.26%
Cap/Sales(3y)144.6%
Cap/Sales(5y)90.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.43%
OCF growth 3YN/A
OCF growth 5YN/A
SCORPIUS HOLDINGS INC / SCPX Fundamental Analysis FAQ
What is the fundamental rating for SCPX stock?
ChartMill assigns a fundamental rating of 2 / 10 to SCPX.
Can you provide the valuation status for SCORPIUS HOLDINGS INC?
ChartMill assigns a valuation rating of 1 / 10 to SCORPIUS HOLDINGS INC (SCPX). This can be considered as Overvalued.
What is the profitability of SCPX stock?
SCORPIUS HOLDINGS INC (SCPX) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for SCPX stock?
The Earnings per Share (EPS) of SCORPIUS HOLDINGS INC (SCPX) is expected to grow by 97.7% in the next year.